Most recent by Jay Chhablani, MD
VIDEO: Phase 2 data focus on pan-VEGF blockers, tyrosine kinase inhibitors in AMD
SEATTLE — In this video from the ARVO meeting, Jay Chhablani, MD, discusses data on pan-VEGF blockers and tyrosine kinase inhibitors for age-related macular degeneration.
VIDEO: AI may assist with detecting progression, conversion of AMD
SEATTLE — In this video from the ARVO meeting, Jay Chhablani, MD, discusses the advancement of AI technology to help predict the progression of age-related macular degeneration and geographic atrophy.
VIDEO: Benefits of better awareness of DME
In this video, Jay Chhablani, MD, professor of ophthalmology at University of Pittsburgh School of Medicine, discusses the latest developments in treatment of diabetic macular edema on the horizon for 2024, the importance of OCT in diagnosis and more.
VIDEO: Biggest challenges in DME care
In this video, Jay Chhablani, MD, professor of ophthalmology at University of Pittsburgh School of Medicine, discusses the latest developments in treatment of diabetic macular edema on the horizon for 2024, the importance of OCT in diagnosis and more.
VIDEO: OCT impact on diagnosis, treatment of DME
In this video, Jay Chhablani, MD, professor of ophthalmology at University of Pittsburgh School of Medicine, discusses the latest developments in treatment of diabetic macular edema on the horizon for 2024, the importance of OCT in diagnosis and more.
VIDEO: Recent developments in DME treatment
In this video, Jay Chhablani, MD, professor of ophthalmology at University of Pittsburgh School of Medicine, discusses the latest developments in treatment of diabetic macular edema on the horizon for 2024, the importance of OCT in diagnosis and more.
VIDEO: How AI impacts diagnosis, treatment of DME
In this video, Jay Chhablani, MD, professor of ophthalmology at University of Pittsburgh School of Medicine, discusses the latest developments in treatment of diabetic macular edema on the horizon for 2024, the importance of OCT in diagnosis and more.
